KROS – keros therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics [Yahoo! Finance]
KROS or ARGX: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Keros Therapeutics (NASDAQ:KROS) was upgraded by analysts at TD Cowen to a "hold" rating.
KROS vs. ARGX: Which Stock Is the Better Value Option? [Yahoo! Finance]
Form 8-K Keros Therapeutics, Inc. For: Jan 09
Form 4 Keros Therapeutics, Inc. For: Jan 07 Filed by: Seehra Jasbir
Form 4 Keros Therapeutics, Inc. For: Nov 21 Filed by: OrbiMed Genesis GP LLC
Form 4 Keros Therapeutics, Inc. For: Nov 21 Filed by: GORDON CARL L
Form 4 Keros Therapeutics, Inc. For: Nov 21 Filed by: Knowles Julius
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.